Breaking News Instant updates and real-time market news.

AUTO

AutoWeb

$1.07 /

-0.04 (-3.60%)

16:31
06/18/20
06/18
16:31
06/18/20
16:31

AutoWeb reports May revenue $5.8M, April revenue $5.3M

AutoWeb is reporting select preliminary unaudited results for May and April 2020. "Given the unprecedented circumstances surrounding the coronavirus pandemic, we are providing an intra-quarter update to be as transparent as we can with our stockholders," said Jared Rowe, President and CEO of AutoWeb. "We have continued to see improvements across our business over the past two months. Our retail dealer 'suspend' status has improved by nearly 70% since mid-April, and we have continued to serve as a strategic partner to both our dealer and OEM customers during this important time. I am incredibly proud of our team's effort to support the consumers and customers that rely upon us. The work we have done over the past two years to make AutoWeb a lean and efficient organization has enabled us to weather the various pandemic-related disruptions to the automotive industry. Consumer demand for new vehicles has dramatically improved since mid-April, and our results have steadily improved alongside those trends into June. If these current trends hold, we continue to believe that our balance sheet and liquidity will see us through this challenging period. In the months ahead, we will continue to prudently manage our costs and remain efficient with our resources. While our work is not done, our preliminary results reflect an important step forward and strong progress in our post-COVID recovery."

  • 18

    Jun

AUTO AutoWeb
$1.07 /

-0.04 (-3.60%)

05/18/20 Ascendiant
AutoWeb price target lowered to $2 from $2.50 at Ascendiant
03/30/20 Lake Street
AutoWeb price target lowered to $2 from $4 at Lake Street
03/30/20 B. Riley FBR
AutoWeb downgraded to Neutral from Buy at B. Riley FBR

TODAY'S FREE FLY STORIES

Recommendations
Progyny price target raised to $32 from $28 at Citi » 06:32
08/06/20
08/06
06:32
08/06/20
06:32
PGNY

Progyny

$27.55 /

+0.33 (+1.21%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

PGNY Progyny
$27.55 /

+0.33 (+1.21%)

07/01/20 SVB Leerink
SVB Leerink bullish on Progyny, initiates with an Outperform
07/01/20 SVB Leerink
Progyny initiated with an Outperform at SVB Leerink
06/02/20 Guggenheim
Guggenheim starts Progyny at Buy, sees opportunity in pullback
06/02/20 Guggenheim
Progyny initiated with a Buy at Guggenheim
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

  • 25
    Oct
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

Recommendations
Nevro price target raised to $160 from $137 at Citi » 06:31
08/06/20
08/06
06:31
08/06/20
06:31
NVRO

Nevro

$137.38 /

+5.27 (+3.99%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

NVRO Nevro
$137.38 /

+5.27 (+3.99%)

06/18/20 Morgan Stanley
Nevro price target raised to $145 from $135 at Morgan Stanley
06/08/20 UBS
Nevro upgraded to Neutral from Sell at UBS
05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

  • 02
    Apr
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

Recommendations
PPD, Inc. price target raised to $37 from $31 at Citi » 06:30
08/06/20
08/06
06:30
08/06/20
06:30
PPD

PPD, Inc.

$32.00 /

+1.1 (+3.56%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

08/05/20 Credit Suisse
PPD, Inc. price target raised to $35 from $30 at Credit Suisse
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 KeyBanc
PPD, Inc. initiated with an Overweight, $35 target at KeyBanc
06/03/20 KeyBanc
PPD, Inc. initiated with an Overweight at KeyBanc
PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

  • 06
    Feb
PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

PPD PPD, Inc.
$32.00 /

+1.1 (+3.56%)

Earnings
Amneal Pharmaceuticals backs FY20 adjusted EPS view 45c-60c, consensus 56c » 06:29
08/06/20
08/06
06:29
08/06/20
06:29
AMRX

Amneal Pharmaceuticals

$5.26 /

+0.59 (+12.63%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

07/27/20 Goldman Sachs
Amneal Pharmaceuticals initiated with a Sell at Goldman Sachs
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral amid generics recovery at Guggenheim
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral from Sell at Guggenheim
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

Recommendations
Fiverr price target raised to $144 from $67 at JMP Securities » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
FVRR

Fiverr

$122.87 /

+18.83 (+18.10%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

08/05/20 Needham
Needham raises Fiverr price target to $155 as business is 'exploding'
08/05/20 Needham
Fiverr price target raised to $155 from $55 at Needham
07/17/20
Fly Intel: Top five analyst downgrades
07/17/20 JPMorgan
Fiverr downgraded to Neutral after 169% rally at JPMorgan
FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

  • 29
    May
FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

FVRR Fiverr
$122.87 /

+18.83 (+18.10%)

Upgrade
Jazz Pharmaceuticals upgraded to Overweight from Equal Weight at Morgan Stanley » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
JAZZ

Jazz Pharmaceuticals

$122.27 /

+12.045 (+10.93%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

06:26 Today Morgan Stanley
Searching... upgraded to Overweight from Equal Weight at Morgan Stanley
07/30/20 Oppenheimer
Avadel Pharmaceuticals initiated with an Outperform at Oppenheimer
07/28/20 Wolfe Research
Jazz Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research
07/23/20 Jefferies
Xywav launch could be key catalyst for Jazz shares, says Jefferies
JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

JAZZ Jazz Pharmaceuticals
$122.27 /

+12.045 (+10.93%)

Earnings
Amneal Pharmaceuticals reports Q2 adjusted EPS 13c, consensus 10c » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
AMRX

Amneal Pharmaceuticals

$5.26 /

+0.59 (+12.63%)

Reports Q2 revenue $465M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

07/27/20 Goldman Sachs
Amneal Pharmaceuticals initiated with a Sell at Goldman Sachs
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral amid generics recovery at Guggenheim
05/12/20 Guggenheim
Amneal Pharmaceuticals upgraded to Neutral from Sell at Guggenheim
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

AMRX Amneal Pharmaceuticals
$5.26 /

+0.59 (+12.63%)

Recommendations
Arista Networks selloff an 'attractive buying opportunity,' says Citi » 06:28
08/06/20
08/06
06:28
08/06/20
06:28
ANET

Arista Networks

$235.28 /

-28.95 (-10.96%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

08/05/20 Wells Fargo
Arista Networks price target raised to $230 from $215 at Wells Fargo
07/24/20 Wolfe Research
Arista Networks initiated with a Peer Perform at Wolfe Research
05/06/20 Wells Fargo
Arista Networks price target raised to $215 from $205 at Wells Fargo
05/06/20 Nomura Instinet
Arista Networks price target raised to $190 from $180 at Nomura Instinet
ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

ANET Arista Networks
$235.28 /

-28.95 (-10.96%)

Earnings
Syneos Health sees FY20 adjusted EPS $3.16-$3.38, consensus $2.98 » 06:27
08/06/20
08/06
06:27
08/06/20
06:27
SYNH

Syneos Health

$65.20 /

+0.43 (+0.66%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

07/16/20 SunTrust
Syneos Health price target raised to $74 from $66 at SunTrust
04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

Earnings
Ares Commercial reports Q2 core EPS 32c, consensus 25c » 06:26
08/06/20
08/06
06:26
08/06/20
06:26
ACRE

Ares Commercial

$9.23 /

+0.205 (+2.27%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRE Ares Commercial
$9.23 /

+0.205 (+2.27%)

ACRE Ares Commercial
$9.23 /

+0.205 (+2.27%)

06/30/20
Fly Intel: Top five analyst upgrades
06/29/20 Keefe Bruyette
Keefe Bruyette upgrades Ares Commercial to Outperform, likes 14.8% yield
06/29/20 Keefe Bruyette
Ares Commercial upgraded to Outperform from Market Perform at Keefe Bruyette
04/27/20 Credit Suisse
Ares Commercial price target lowered to $9 from $17.50 at Credit Suisse
ACRE Ares Commercial
$9.23 /

+0.205 (+2.27%)

  • 23
    Jan
Earnings
Syneos Health reports Q2 adjusted EPS 58c, consensus 48c » 06:26
08/06/20
08/06
06:26
08/06/20
06:26
SYNH

Syneos Health

$65.20 /

+0.43 (+0.66%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

07/16/20 SunTrust
Syneos Health price target raised to $74 from $66 at SunTrust
04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

SYNH Syneos Health
$65.20 /

+0.43 (+0.66%)

Recommendations
Karuna Therapeutics price target lowered to $130 from $140 at H.C. Wainwright » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
KRTX

Karuna Therapeutics

/

+

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
/

+

KRTX Karuna Therapeutics
/

+

06/24/20 Oppenheimer
Karuna Therapeutics price target raised to $135 from $125 at Oppenheimer
06/02/20 Wedbush
Karuna Therapeutics price target raised to $126 from $117 at Wedbush
06/01/20 Goldman Sachs
Karuna price target raised to $131 from $115 at Goldman Sachs
05/31/20 Stifel
Karuna schizophrenia drug has blockbuster potential, says Stifel
KRTX Karuna Therapeutics
/

+

  • 23
    Jan
  • 21
    Nov
Downgrade
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
PAHC

Phibro Animal Health

$23.85 /

+0.4 (+1.71%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAHC Phibro Animal Health
$23.85 /

+0.4 (+1.71%)

PAHC Phibro Animal Health
$23.85 /

+0.4 (+1.71%)

02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
01/28/20 Barclays
Barclays upgrades Phibro to Equal Weight after underperformance
01/28/20 Barclays
Phibro Animal Health upgraded to Equal Weight from Underweight at Barclays
PAHC Phibro Animal Health
$23.85 /

+0.4 (+1.71%)

Upgrade
Infinera upgraded to Buy ahead of ICE6 delivery at Rosenblatt » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
INFN

Infinera

$7.80 /

-0.315 (-3.88%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFN Infinera
$7.80 /

-0.315 (-3.88%)

INFN Infinera
$7.80 /

-0.315 (-3.88%)

05:21 Today Rosenblatt
Infinera upgraded to Buy from Neutral at Rosenblatt
08/03/20 Jefferies
Jefferies says Ciena could take share from Huawei in Europe faster than expected
07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/24/20 Wolfe Research
Infinera initiated with an Underperform at Wolfe Research
INFN Infinera
$7.80 /

-0.315 (-3.88%)

INFN Infinera
$7.80 /

-0.315 (-3.88%)

INFN Infinera
$7.80 /

-0.315 (-3.88%)

Earnings
Titan International reports Q2 EPS (8c), consensus (36c) » 06:25
08/06/20
08/06
06:25
08/06/20
06:25
TWI

Titan International

$1.61 /

+0.01 (+0.63%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWI Titan International
$1.61 /

+0.01 (+0.63%)

TWI Titan International
$1.61 /

+0.01 (+0.63%)

Upgrade
GoDaddy upgraded to Strong Buy from Outperform at Raymond James » 06:24
08/06/20
08/06
06:24
08/06/20
06:24
GDDY

GoDaddy

$74.46 /

+1.125 (+1.53%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

06:21 Today Raymond James
GoDaddy upgraded to Strong Buy at Raymond James after 'solid' Q2 results
04:46 Today Raymond James
GoDaddy upgraded to Strong Buy from Outperform at Raymond James
04:42 Today JPMorgan
GoDaddy upgraded to Overweight from Neutral at JPMorgan
07/16/20 Barclays
GoDaddy risk/reward attractive at current share levels, says Barclays
GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

Earnings
State Auto Financial reports Q2 EPS (59c), consensus (76c) » 06:24
08/06/20
08/06
06:24
08/06/20
06:24
STFC

State Auto Financial

$16.04 /

+0.8 (+5.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STFC State Auto Financial
$16.04 /

+0.8 (+5.25%)

STFC State Auto Financial
$16.04 /

+0.8 (+5.25%)

07/16/20 Sidoti
State Auto Financial initiated with a Neutral at Sidoti
05/19/20 Keefe Bruyette
State Auto Financial price target lowered to $24 from $28 at Keefe Bruyette
STFC State Auto Financial
$16.04 /

+0.8 (+5.25%)

Upgrade
Summit Materials upgraded to Overweight with $20 target at JPMorgan » 06:24
08/06/20
08/06
06:24
08/06/20
06:24
SUM

Summit Materials

$16.56 /

+1.17 (+7.60%)

JPMorgan analyst Adrian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SUM Summit Materials
$16.56 /

+1.17 (+7.60%)

SUM Summit Materials
$16.56 /

+1.17 (+7.60%)

04:43 Today JPMorgan
Summit Materials upgraded to Overweight from Neutral at JPMorgan
07/23/20
Fly Intel: Top five analyst upgrades
07/23/20 Loop Capital
Summit Materials upgraded to Buy from Hold at Loop Capital
07/23/20 Loop Capital
Summit Materials upgraded to Buy from Hold at Loop Capital
SUM Summit Materials
$16.56 /

+1.17 (+7.60%)

Earnings
Sierra Wireless reports Q2 non-GAAP EPS (30c), consensus (35c) » 06:23
08/06/20
08/06
06:23
08/06/20
06:23
SWIR

Sierra Wireless

$13.00 /

-0.165 (-1.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWIR Sierra Wireless
$13.00 /

-0.165 (-1.25%)

SWIR Sierra Wireless
$13.00 /

-0.165 (-1.25%)

02/14/20 Roth Capital
Roth Capital sees upside in Sierra Wireless after 2020 transition year
11/06/19 Raymond James
Sierra Wireless downgraded to Market Perform from Outperform at Raymond James
11/06/19 RBC Capital
Sierra Wireless price target lowered to $12 from $14 at RBC Capital
SWIR Sierra Wireless
$13.00 /

-0.165 (-1.25%)

SWIR Sierra Wireless
$13.00 /

-0.165 (-1.25%)

Earnings
KBR backs FY20 adj. EPS view of $1.50-$1.80, consensus $1.63 » 06:23
08/06/20
08/06
06:23
08/06/20
06:23
KBR

KBR

$23.68 /

+0.7 (+3.05%)

KBR said in its Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$23.68 /

+0.7 (+3.05%)

KBR KBR
$23.68 /

+0.7 (+3.05%)

06/15/20 Citi
KBR price target raised to $29 from $25 at Citi
06/03/20 Goldman Sachs
KBR upgraded to Buy from Neutral at Goldman Sachs
06/03/20 Goldman Sachs
Wabtec downgraded to Neutral from Buy at Goldman Sachs
05/26/20 UBS
KBR upgraded to Buy from Neutral at UBS
KBR KBR
$23.68 /

+0.7 (+3.05%)

Earnings
Vereit reports Q2 AFFO 15c, consensus 15c » 06:23
08/06/20
08/06
06:23
08/06/20
06:23
VER

Vereit

$6.57 /

+0.025 (+0.38%)

Reports Q2 revenue $279M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VER Vereit
$6.57 /

+0.025 (+0.38%)

VER Vereit
$6.57 /

+0.025 (+0.38%)

07/10/20 Berenberg
Vereit initiated with a Hold at Berenberg
04/24/20 Mizuho
Store Capital downgraded to Neutral from Buy at Mizuho
02/10/20 Capital One
Vereit downgraded to Equalweight from Overweight at Capital One
10/25/19 BMO Capital
Vereit initiated with an Outperform at BMO Capital
VER Vereit
$6.57 /

+0.025 (+0.38%)

  • 24
    Sep
Downgrade
Martin Marietta downgraded to Neutral with $250 target at JPMorgan » 06:22
08/06/20
08/06
06:22
08/06/20
06:22
MLM

Martin Marietta

$216.79 /

+4.59 (+2.16%)

JPMorgan analyst Adrian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MLM Martin Marietta
$216.79 /

+4.59 (+2.16%)

MLM Martin Marietta
$216.79 /

+4.59 (+2.16%)

04:43 Today JPMorgan
Martin Marietta downgraded to Neutral from Overweight at JPMorgan
06/22/20 Loop Capital
Vulcan Materials, Martin Marietta price targets raised at Loop Capital
06/19/20 Atlantic Equities
Atlantic Equities starts Martin Marietta at Overweight with faster growth seen
06/19/20 Atlantic Equities
Martin Marietta initiated with an Overweight at Atlantic Equities
MLM Martin Marietta
$216.79 /

+4.59 (+2.16%)

MLM Martin Marietta
$216.79 /

+4.59 (+2.16%)

MLM Martin Marietta
$216.79 /

+4.59 (+2.16%)

Syndicate
Avalara 3.937M share Spot Secondary priced at $127.00 » 06:22
08/06/20
08/06
06:22
08/06/20
06:22
AVLR

Avalara

$133.42 /

-3.435 (-2.51%)

Goldman Sachs, BofA,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVLR Avalara
$133.42 /

-3.435 (-2.51%)

AVLR Avalara
$133.42 /

-3.435 (-2.51%)

06/24/20 Needham
Avalara price target raised to $150 from $116 at Needham
06/24/20 Canaccord
Avalara price target raised to $150 from $115 at Canaccord
06/24/20 Goldman Sachs
Avalara price target raised to $154 from $117 at Goldman Sachs
06/24/20 Mizuho
Avalara price target raised to $150 from $120 at Mizuho
AVLR Avalara
$133.42 /

-3.435 (-2.51%)

  • 06
    Aug
  • 22
    Aug
AVLR Avalara
$133.42 /

-3.435 (-2.51%)

Recommendations
Carvana price target raised to $200 from $155 at JMP Securities » 06:22
08/06/20
08/06
06:22
08/06/20
06:22
CVNA

Carvana

$174.42 /

+7.94 (+4.77%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$174.42 /

+7.94 (+4.77%)

CVNA Carvana
$174.42 /

+7.94 (+4.77%)

05:06 Today Baird
Carvana price target raised to $195 from $148 at Baird
08/05/20 B. Riley FBR
Carvana price target raised to $190 from $100 at B. Riley FBR
07/29/20 Needham
Carvana price target raised to $200 from $135 at Needham
07/27/20 Piper Sandler
Piper puts $211 price target, Overweight rating on Carvana
CVNA Carvana
$174.42 /

+7.94 (+4.77%)

  • 19
    May
CVNA Carvana
$174.42 /

+7.94 (+4.77%)

CVNA Carvana
$174.42 /

+7.94 (+4.77%)

CVNA Carvana
$174.42 /

+7.94 (+4.77%)

Earnings
Colfax not providing financial guidance for 2020 » 06:22
08/06/20
08/06
06:22
08/06/20
06:22
CFX

Colfax

$31.20 /

+0.65 (+2.13%)

Given the uncertainties…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFX Colfax
$31.20 /

+0.65 (+2.13%)

CFX Colfax
$31.20 /

+0.65 (+2.13%)

07/13/20 Morgan Stanley
Illinois Tool Works downgraded to Underweight at Morgan Stanley
05/29/20 JPMorgan
Colfax initiated with an Overweight at JPMorgan
05/11/20 Northcoast
Colfax upgraded to Buy on DJO strength, cost cutting benefits at Northcoast
05/11/20 Northcoast
Colfax upgraded to Buy from Neutral at Northcoast
CFX Colfax
$31.20 /

+0.65 (+2.13%)

  • 01
    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.